Company · CIK 1697532
Applied Therapeutics, Inc.
| CIK | 1697532 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-06-21 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271887 | 2023-05-12 | 2026-02-06 | 5 | |
| 333-278182 | 2024-03-22 | 2026-02-06 | 3 | |
| 333-238948 | 2020-06-05 | 2022-06-24 | 7 | |
| 333-235504 | 2019-12-13 | 2020-06-09 | 6 | |
| 333-235988 | 2020-01-21 | 2020-01-24 | 4 | |
| 333-230838 | 2019-04-12 | 2019-05-14 | 5 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-02-06 | EFFECTDeclared effective | 333-278182 | 9999999995-26-000463 |
| 2026-02-06 | EFFECTDeclared effective | 333-271887 | 9999999995-26-000461 |
| 2025-08-29 | 424B5Shelf takedown | 333-271887 | 0000950170-25-112222 |
| 2024-04-25 | EFFECTDeclared effective | 333-278182 | 9999999995-24-001125 |
| 2024-03-22 | S-3Shelf registered | 333-278182 | 0001104659-24-037897 |
| 2023-08-11 | 424B5Shelf takedown | 333-271887 | 0001104659-23-090540 |
| 2023-05-19 | EFFECTDeclared effective | 333-271887 | 9999999995-23-001484 |
| 2023-05-12 | S-3Shelf registered | 333-271887 | 0001104659-23-059815 |
| 2022-06-24 | 424B5Shelf takedown | 333-238948 | 0001104659-22-074347 |
| 2022-06-22 | 424B5Shelf takedown | 333-238948 | 0001104659-22-073513 |
| 2022-01-26 | 424B5Shelf takedown | 333-238948 | 0001104659-22-007645 |
| 2021-02-12 | 424B5Shelf takedown | 333-238948 | 0001104659-21-022146 |
| 2021-02-11 | 424B5Shelf takedown | 333-238948 | 0001104659-21-020043 |
| 2020-06-15 | EFFECTDeclared effective | 333-238948 | 9999999995-20-001430 |
| 2020-06-09 | EFFECTDeclared effective | 333-235504 | 9999999995-20-001375 |
| 2020-06-05 | S-3Shelf registered | 333-238948 | 0001104659-20-069963 |
| 2020-03-23 | EFFECTDeclared effective | 333-235504 | 9999999995-20-000607 |
| 2020-01-24 | 424B4Final prospectus | 333-235988 | 0001047469-20-000481 |
| 2020-01-23 | EFFECTDeclared effective | 333-235988 | 9999999995-20-000151 |
| 2020-01-23 | S-1/AAmendment | 333-235988 | 0001047469-20-000444 |
| 2020-01-21 | S-1Registration filed | 333-235988 | 0001047469-20-000339 |
| 2020-01-10 | DRSDraft made public | 377-02992 | 0000912057-20-000011 |
| 2019-12-23 | 424B4Final prospectus | 333-235504 | 0001047469-19-006940 |
| 2019-12-20 | EFFECTDeclared effective | 333-235504 | 9999999995-19-002895 |
| 2019-12-19 | S-1/AAmendment | 333-235504 | 0001047469-19-006897 |
| 2019-12-13 | S-1Registration filed | 333-235504 | 0001047469-19-006843 |
| 2019-05-14 | 424B4Final prospectus | 333-230838 | 0001047469-19-003094 |
| 2019-05-13 | EFFECTDeclared effective | 333-230838 | 9999999995-19-001102 |
| 2019-04-29 | S-1/AAmendment | 333-230838 | 0001047469-19-002659 |
| 2019-04-24 | S-1/AAmendment | 333-230838 | 0001047469-19-002548 |
| 2019-04-12 | S-1Registration filed | 333-230838 | 0001047469-19-002204 |
| 2019-01-25 | DRSDraft made public | 377-02475 | 0000912057-19-000026 |